Today ATAGI extends the recommendation of a booster dose to include all individuals aged 16-17 years - from 3 months after receiving their last primary dose. This includes those who were aged under 16 years when they received their last primary dose and are now aged 16 years.

Pfizer vaccine is the only brand currently registered for use as a booster dose in this age group

Adolescents aged 16-17 years who are severely immunocompromised and have received a third primary dose of COVID-19 vaccine should also receive a booster dose (4th dose) of the Pfizer vaccine from 3 months after receiving their third primary dose.

Adolescents who have recently had SARS-CoV-2 infection and are now eligible for a booster are recommended to receive their booster dose. This booster dose can be administered immediately after recovery from acute illness or can be deferred for up to 4 months.